Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Immunocore Holdings (IMCR) FCF Margin (2023 - 2025)

Immunocore Holdings' FCF Margin history spans 3 years, with the latest figure at 34.01% for Q4 2025.

  • For Q4 2025, FCF Margin fell 1315.0% year-over-year to 34.01%; the TTM value through Dec 2025 reached 3.76%, down 1050.0%, while the annual FY2025 figure was 3.76%, 1050.0% down from the prior year.
  • FCF Margin for Q4 2025 was 34.01% at Immunocore Holdings, down from 5.02% in the prior quarter.
  • Across five years, FCF Margin topped out at 30.69% in Q2 2024 and bottomed at 34.01% in Q4 2025.
  • The 3-year median for FCF Margin is 1.06% (2023), against an average of 1.29%.
  • The largest annual shift saw FCF Margin surged 3295bps in 2024 before it tumbled -3031bps in 2025.
  • A 3-year view of FCF Margin shows it stood at 26.44% in 2023, then rose by 21bps to 20.86% in 2024, then tumbled by -63bps to 34.01% in 2025.
  • Per Business Quant, the three most recent readings for IMCR's FCF Margin are 34.01% (Q4 2025), 5.02% (Q3 2025), and 26.08% (Q2 2025).